GREENFIELD, Ind. — Pulmotil AC, an aqueous concentrate formulation for controlling swine respiratory disease associated with Pasteurella multocida and Haemophilus parasuis in groups of swine in buildings where a respiratory disease outbreak is diagnosed, is now approved. Veterinarians who treat swine can begin prescribing the medication in April when the product is available.
As a liquid concentrate, Pulmotil AC works fast. There’s no need to formulate new rations or wait for bins to empty. Nor is flushing or sequencing required.
It’s cost-effective as well, eliminating labor costs associated with injectable treatments.*
“The effectiveness of Pulmotil is well-established,” said Dr. Tom Marsteller, Director of Technical Services for Elanco. “This new liquid option for groups of swine in buildings where a respiratory disease outbreak has been diagnosed should prove advantageous because it gets the medication to the right pigs at the right time and it provides flexibility to veterinarians and clients."